title: Late-onset Epstein-Barr virus (EBV)-negative extranodal B-precursor lymphoblastic lymphoma of donor origin after hematopoietic stem cell transplantation (HSCT).
authors.forename: M
authors.initials: M
authors.lastname: Bredt
authors.forename: G
authors.initials: G
authors.lastname: Schönfeld
authors.forename: W
authors.initials: W
authors.lastname: Kleeberger
authors.forename: E
authors.initials: E
authors.lastname: König
authors.forename: H
authors.initials: H
authors.lastname: Kröning
authors.forename: E
authors.initials: E
authors.lastname: Kettner
authors.forename: H K
authors.initials: HK
authors.lastname: Al-Ali
authors.forename: D
authors.initials: D
authors.lastname: Niederwieser
authors.forename: H
authors.initials: H
authors.lastname: Kreipe
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D002051:Burkitt Lymphoma / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology / Q000235:genetics; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D004854:Herpesvirus 4, Human / Q000302:isolation & purification*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D008297:Male; D016609:Neoplasms, Second Primary / Q000175:diagnosis*; D011241:Prednisone / Q000008:administration & dosage; D013997:Time Factors; D014185:Transplantation, Isogeneic; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone